Nintedanib or BIBF 1120 CAS No.656247-17-5, is a tyrosine kinase inhibitor of (VEGFR) vascular endothelial growth factor receptor,(FGFR) fibroblast growth factor receptor,(PDGFR) platelet-derived growth factor receptor, and the chemical formula is C31H33N5O4.Approved by the FDA. For more information visits our bank website http://www.eosmedchem.com/656247-17-5.html
Original Title
Nintedanib (BIBF 1120)|VEGFR/PDGFR/FGFR Inhibitor|EOS Med Chem
Nintedanib or BIBF 1120 CAS No.656247-17-5, is a tyrosine kinase inhibitor of (VEGFR) vascular endothelial growth factor receptor,(FGFR) fibroblast growth factor receptor,(PDGFR) platelet-derived growth factor receptor, and the chemical formula is C31H33N5O4.Approved by the FDA. For more information visits our bank website http://www.eosmedchem.com/656247-17-5.html
Nintedanib or BIBF 1120 CAS No.656247-17-5, is a tyrosine kinase inhibitor of (VEGFR) vascular endothelial growth factor receptor,(FGFR) fibroblast growth factor receptor,(PDGFR) platelet-derived growth factor receptor, and the chemical formula is C31H33N5O4.Approved by the FDA. For more information visits our bank website http://www.eosmedchem.com/656247-17-5.html
VEGFR/PDGFR/FGFR Inhibitor EOS Med Chem Nintedanib BIBF 1120 656247-17-5
Nintedanib or BIBF 1120 CAS No.656247-17-5, is a
tyrosine kinase inhibitor of (VEGFR) vascular endothelial growth factor receptor,(FGFR) fibroblast growth factor receptor,(PDGFR) platelet-derived growth factor receptor, and the chemical formula is C31H33N5O4.Approved by the FDA . For more information visits our bank website http://www.eosmedchem.com/656247-17-5.html ABOUT US
EOS Med Chem is the largest chemistry products
and services provider based in China. It is Centre organizations include an index of unusually created frameworks and building blocks; custom amalgamation; prepare advancement; and assembling of key intermediates. EOS Med Chem likewise gives high Calibre and financially savvy custom synthesis service. For more info visit http://www.eosmedchem.com/ Nintedanib BIBF 1120 656247-17-5 is reduce decline in FVC compared to placebo Basic Details Of Nintedanib BIBF 1120 656247-17-5